Stockscreener 앱 받기
0.395
3.67%
0.014
전일 마감가:
$0.381
열려 있는:
$0.41
하루 거래량:
218.79K
Relative Volume:
0.85
시가총액:
$24.76M
수익:
$64.42M
순이익/손실:
$-73.78M
주가수익비율:
-
EPS:
-
순현금흐름:
$-60.50M
1주 성능:
-13.72%
1개월 성능:
-48.03%
6개월 성능:
-75.77%
1년 성능:
-90.25%
1일 변동 폭
$0.3624
$0.415
1주일 범위
$0.3624
$0.5699
52주 변동 폭
$0.31
$4.15
Allurion Technologies Inc Stock (ALUR) Company Profile
명칭
Allurion Technologies Inc
전화
508-647-4000
주소
11 HURON DR STE 200, NATICK
ALUR을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ALUR
Allurion Technologies Inc
|
0.395 | 24.76M | 64.42M | -73.78M | -60.50M | 0.00 |
|
ABT
Abbott Laboratories
|
118.95 | 208.18B | 41.22B | 5.77B | 6.49B | 2.94 |
|
SYK
Stryker Corp
|
388.14 | 148.70B | 21.97B | 3.59B | 3.21B | 6.74 |
|
BSX
Boston Scientific Corp
|
90.75 | 133.32B | 15.91B | 1.79B | 1.89B | 0.82 |
|
MDT
Medtronic Plc
|
86.27 | 111.27B | 33.00B | 4.29B | 5.50B | 2.71 |
|
EW
Edwards Lifesciences Corp
|
72.07 | 42.66B | 6.60B | 4.16B | 490.10M | 2.34 |
Allurion Technologies Inc Stock (ALUR) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-11-14 | 다운그레이드 | Chardan Capital Markets | Buy → Neutral |
| 2024-10-02 | 개시 | TD Cowen | Buy |
| 2024-09-06 | 개시 | ROTH MKM | Buy |
| 2024-02-09 | 개시 | Jefferies | Buy |
Allurion Technologies Inc 주식(ALUR)의 최신 뉴스
Allurion launches AI weight loss support GLP-1 drug programme - Yahoo! Voices
Allurion launches compounded GLP-1 program as FDA aims to end access - Yahoo Finance
Allurion launches compounded GLP-1 program as FDA aims to ends access - Yahoo Finance
Allurion Launches in the US with its First AI-Native Compounded GLP-1 Program - The Bakersfield Californian
Allurion Technologies (NYSE:ALUR) Cut to Neutral at Chardan Capital - Defense World
Earnings Release: Here's Why Analysts Cut Their Allurion Technologies Inc. (NYSE:ALUR) Price Target To US$1.83 - Yahoo Finance
Take Care Before Jumping Onto Allurion Technologies Inc. (NYSE:ALUR) Even Though It's 42% Cheaper - Simply Wall St
Analysis of ARMISTICE CAPITAL, LLC's Recent Transaction in Allur - GuruFocus.com
Allurion Technologies Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag - Yahoo Finance
Citadel Advisors LLC Acquires New Stake in Allurion Technologies Inc - GuruFocus.com
TD Cowen maintains buy rating for Allurion Technologies at $2.00 target - Investing.com UK
Earnings call: Allurion Technologies outlines strategy amid Q3 challenges - Investing.com
Earnings call: Allurion Technologies outlines strategy amid Q3 challenges By Investing.com - Investing.com Australia
Chardan Capital Downgrades Allurion Technologies (ALUR) - MSN
Allurion Technologies Inc (ALUR) Q3 2024 Earnings Call Highlights: Strategic Shifts and Revenue ... By GuruFocus - Investing.com Canada
Allurion Technologies Reports Q3 2024 Financial Performance - TipRanks
Allurion Technologies CFO Resigns, CEO Steps In - TipRanks
Allurion Technologies announces 50% reduction in workforce, operating expenses - Nasdaq
Allurion Technologies Inc. Announces Chief Financial Officer Changes - Marketscreener.com
Allurion Reports Third Quarter 2024 Financial Results and Provides Business Update - Marketscreener.com
Allurion Technologies (ALUR) Scheduled to Post Earnings on Wednesday - Defense World
Allurion boasts over 17% weight loss with swallowable balloon device - Yahoo Finance
Allurion reports significant weight loss in global patient study By Investing.com - Investing.com Canada
Allurion reports significant weight loss in global patient study - Investing.com India
Allurion Technologies presents data at Obesity Week - Nasdaq
Allurion Presents Data From Largest Ever Real-World Experience of 19,428 Patients at The Obesity Society’s Annual Conference - Business Wire
Allurion to Report Third Quarter 2024 Financial Results on November 13, 2024 - Marketscreener.com
Allurion sets date for first annual stockholders meeting By Investing.com - Investing.com Canada
Allurion sets date for first annual stockholders meeting - Investing.com
Allurion Technologies : Proxy Statement Form 8 K - Marketscreener.com
Allurion Technologies, Inc. Announces Submission of First Three Modules of Premarket Approval Application to the U.S. Food and Drug Administration for the Allurion Balloon - Marketscreener.com
RTW INVESTMENTS, LP Reduces Stake in Allurion Technologies Inc - GuruFocus.com
ALUR Stock Declines Despite Submitting PMA for Allurion Balloon - Yahoo Finance
Allurion Technologies (NYSE:ALUR) Shares Down 3.8% – Time to Sell? - Defense World
Allurion Announces Submission of First Three Modules of Premarket Approval Application to the U.S. Food and Drug Administration for the Allurion Balloon - Marketscreener.com
Allurion reports weight loss success with gastric balloon By Investing.com - Investing.com South Africa
October's 4 Best Penny Stocks: High-Risk, High-Reward Picks - Benzinga
Allurion’s swallowable balloon hits trial success amid weakening financials - Yahoo! Voices
Allurion reports weight loss success with gastric balloon - Investing.com India
Allurion Announces Publication of New Data Demonstrating Muscle Mass Preservation in Patients Experiencing 15% Weight Loss - Marketscreener.com
Gevo Inc (GEVO-Q) QuotePress Release - The Globe and Mail
ALUR Stock Update: Allurion Technologies Inc’s Banking’s Market Struggles and Potential Opportunities - The InvestChronicle
TD Cowen Initiates Coverage of Allurion Technologies (ALUR) with Buy Recommendation - Nasdaq
PHLX Swiss Franc (XDS) QuotePress Release - The Globe and Mail
U.S. Dollar Index (DXY) QuotePress Release - The Globe and Mail
S&P 500 Index (INX) QuotePress Release - The Globe and Mail
S&P 500 Industrials [Sector] (SRIN) QuotePress Release - The Globe and Mail
Allurion Technologies Inc (ALUR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.65%
자본화:
|
볼륨(24시간):